Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-017961·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
Ordinary Shares, $0.001 par value per share · CUSIP: 38000Q201
Event date: 2025-06-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 1,391,196.00 · Class: 9.9%
- VHCP Co-Investment Holdings III, LLC
Shares: 1,391,196.00 · Class: 9.9%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 1,391,196.00 · Class: 9.9%
- VHCP Management III, LLC
Shares: 1,391,196.00 · Class: 9.9%
- VHCP Management EG, LLC
Shares: 1,391,196.00 · Class: 9.9%
- Nimish Shah
Shares: 1,391,196.00 · Class: 9.9%
- Bong Y. Koh
Shares: 1,391,196.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-017961
- Form type
- SCHEDULE 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Jun 23, 2025
- Reporting period
- Jun 13, 2025
- Description
- Schedule 13G beneficial ownership